Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis
Journal article
Peris Sempere V. et al, (2022), Neurology - Neuroimmunology Neuroinflammation, 9, e1140 - e1140
Autoimmune encephalitis: clinical spectrum and management.
Journal article
Uy CE. et al, (2021), Pract Neurol, 21, 412 - 423
Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons
Journal article
Ramanathan S. et al, (2021), Annals of Neurology, 90, 683 - 690
Paraneoplastic neurological syndromes: a practical approach to diagnosis and management.
Journal article
Binks S. et al, (2021), Pract Neurol
Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
Journal article
Binks SNM. et al, (2021), JAMA Neurol, 78, 617 - 619
Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology.
Journal article
Binks S. and Irani SR., (2020), J Neurol Neurosurg Psychiatry, 91, 1033 - 1034
'LESS CONTENTED AS A PERSON': AN UPDATE FROM THE LGI1-QOL STUDY
Conference paper
Binks S. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E34 - E34
Distinct HLA associations of LGI1 and CASPR2-antibody diseases
Journal article
Binks S. et al, (2018), Brain, 141, 2263 - 2271
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
Journal article
Binks SNM. et al, (2018), Journal of Neurology, Neurosurgery & Psychiatry, 89, 526 - 534
‘Less contented as a person’: preliminary data from the lgi1-qol study
Conference paper
Binks SNM. et al, (2017), Journal of Neurology, Neurosurgery and Psychiatry, 88, A7 - A7
Contactin-2 associated protein (CASPR2) autoimmune neurological conditions: Detailed clinical phenotype and antibody quantification
Conference paper
Varley J. et al, (2017), Journal of the Neurological Sciences, 381, 909 - 910
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.
Journal article
Chan D. et al, (2017), Lancet Neurol, 16, 591 - 600
The assessment of headaches on the acute medical unit: is it adequate and how could it be improved? .
Journal article
Binks S. et al, (2017), Clin Med (Lond), 17, 114 - 120
Myasthenia gravis: a clinical-immunological update
Journal article
Binks S. et al, (2016), Journal of Neurology, 263, 826 - 834
FRONT DOOR NEUROLOGY: THE GP EXPERIENCE
Conference paper
Binks S. and Green L., (2015), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86
MANAGEMENT OF SUSPECTED ENCEPHALITIS IN A UK TEACHING HOSPITAL
Conference paper
Binks S. et al, (2015), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86
THE PROFILE OF MULTIPLE SCLEROSIS IN GENERAL PRACTICE
Conference paper
Binks S. and Green L., (2015), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86
Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies.
Journal article
Canazza A. et al, (2014), Front Neurol, 5
SETTING THE STANDARDS: AUDITING MANAGEMENT OF FIRST SEIZURE IN THE EMERGENCY DEPARTMENT OF A UK TEACHING CENTRE
Conference paper
Binks S. et al, (2013), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 84